GP41 PEPTIDES AND METHODS BASED-THEREON FOR INHIBITING HIV FUSION TO TARGET CELLS

摘要

The present invention provides peptides which are based on the HIV GP41 protein and have inhibitory activity against the fusion of HIV virus to its target cells. The invention also provides therapeutic methods based on the administration of the peptides of the invention to a subject infected with the HIV virus.